RESUMEN
We evaluated how the mild stress-induced increase in endogenous corticosterone affected the pineal gland in Syrian hamsters (Mesocricetus auratus). The animals were maintained under constant light for 1 day, instead of a cycle of 14:10-h, to increase the circulating corticosterone levels during the daytime. The nuclear translocation of nuclear factor kappa B (NFKB), which is the pivotal transcription factor for stress and injury, presented a daily rhythm in normal animals. NFKB nuclear content increased linearly from the onset of light [Zeitgeber Time 0 (ZT0)] until ZT11 and decreased after ZT12 when the plasma corticosterone peak was detected in normal animals. However, the 24-h profiles of the two curves were different, and they did not clearly support an exclusive relationship between corticosterone levels and NFKB content. Therefore, we tested the effect of increased endogenous corticosterone through inducing mild stress by maintaining daytime illumination for one night. This stressful condition, which increased daytime corticosterone levels, resulted in a daytime decrease in NFKB nuclear content, and this was inhibited by mifepristone. Overall, this study shows that NFKB has a daily rhythm in Syrian hamster pineal glands and, by increasing endogenous corticosterone with a stressful condition, NFKB activity is regulated. Therefore, this study suggests that the pineal gland in the Syrian hamster is a sensor of stressful conditions.
Asunto(s)
Corticosterona/sangre , Corticosterona/fisiología , FN-kappa B/metabolismo , FN-kappa B/fisiología , Glándula Pineal/metabolismo , Glándula Pineal/fisiología , Animales , Cricetinae , Interpretación Estadística de Datos , Ensayo de Cambio de Movilidad Electroforética , Femenino , Luz , Melatonina/sangre , Melatonina/farmacología , Mesocricetus , Sondas de Oligonucleótidos , Radioinmunoensayo , Receptores de Glucocorticoides/antagonistas & inhibidores , Estrés Psicológico/sangreRESUMEN
BACKGROUND AND PURPOSE: We have shown that endogenous glucocorticoids control neutrophil mobilization in the absence of inflammation. In this study the role of the glucocorticoid receptor (GR) in the physiological control of neutrophil mobilization was investigated, focusing on the specific mechanisms for mature neutrophils in bone marrow, circulating neutrophils and endothelial cells. EXPERIMENTAL APPROACH: Male Wistar rats were treated with RU 38486 or adrenalectomized. Cell numbers in bone marrow and circulation were morphologically quantified and expressions of L-selectin determined by flow cytometry. Expressions of P-selectin, E-selectin, PECAM-1, VCAM-1 and ICAM-1 were measured by immunohistochemistry on vessels of cremaster muscle and their mRNA levels quantified in primary cultured endothelial cells. NF-kappaB activity in neutrophils and endothelium was quantified by EMSA. KEY RESULTS: RU 38486 treatment altered the maturation phases of neutrophilic lineage and reduced expression of L-selectin in mature neutrophils from bone marrow; increased the number of neutrophils in the circulation and elevated the expression of L-selectin in these cells. P-selectin and E-selectin expression in endothelial cells was unchanged by adrenalectomy or RU 38486 treatment. Membrane expressions, mRNA levels of ICAM-1, VCAM-1 and PECAM-1 and NF-kappaB translocation into the nucleus were higher in the endothelium of adrenalectomized and RU 38486 treated rats. CONCLUSIONS AND IMPLICATIONS: Endogenous glucocorticoids, through activation of GR on neutrophils, physiologically control the rolling behaviour of these cells and, by modulating endothelial functions, affect their adhesiveness. The molecular mechanism induced by activated GR is different in each cell, as NF-kappaB translocation was only altered in endothelial cells.
Asunto(s)
Glucocorticoides/metabolismo , Neutrófilos/metabolismo , Receptores de Glucocorticoides/metabolismo , Adrenalectomía , Animales , Médula Ósea/metabolismo , Células Endoteliales/metabolismo , Citometría de Flujo , Regulación de la Expresión Génica , Inmunohistoquímica , Molécula 1 de Adhesión Intercelular/metabolismo , Selectina L/metabolismo , Masculino , Mifepristona , FN-kappa B/metabolismo , Molécula-1 de Adhesión Celular Endotelial de Plaqueta/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Molécula 1 de Adhesión Celular Vascular/metabolismoRESUMEN
BACKGROUND AND PURPOSE: We have previously shown that melatonin inhibits bradykinin-induced NO production by endothelial cells in vitro. The purpose of this investigation was to extend this observation to an in vivo condition and to explore the mechanism of action of melatonin. EXPERIMENTAL APPROACH: RT-PCR assays were performed with rat cultured endothelial cells. The putative effect of melatonin upon arteriolar tone was investigated by intravital microscopy while NO production by endothelial cells in vitro was assayed by fluorimetry, and intracellular Ca(2+) measurements were assayed by confocal microscopy. KEY RESULTS: No expression of the mRNA for the melatonin synthesizing enzymes, arylalkylamine N-acetyltransferase and hydroxyindole-O-methyltransferase, or for the melatonin MT(2) receptor was detected in microvascular endothelial cells. Melatonin fully inhibited L-NAME-sensitive bradykinin-induced vasodilation and also inhibited NO production induced by histamine, carbachol and 2-methylthio ATP, but did not inhibit NO production induced by ATP or alpha, beta-methylene ATP. None of its inhibitory effects was prevented by the melatonin receptor antagonist, luzindole. In nominally Ca(2+)-free solution, melatonin reduced intracellular Ca(2+) mobilization induced by bradykinin (40%) and 2-methylthio ATP (62%) but not Ca(2+) mobilization induced by ATP. CONCLUSIONS AND IMPLICATIONS: We have confirmed that melatonin inhibited NO production both in vivo and in vitro. In addition, the melatonin effect was selective for some G protein-coupled receptors and most probably reflects an inhibition of Ca(2+) mobilization from intracellular stores.
Asunto(s)
Células Endoteliales/efectos de los fármacos , Melatonina/farmacología , Arterias Mesentéricas/efectos de los fármacos , Óxido Nítrico/biosíntesis , Acetilserotonina O-Metiltransferasa/genética , Adenosina Trifosfato/farmacología , Animales , N-Acetiltransferasa de Arilalquilamina/genética , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Calcio/metabolismo , Carbacol/farmacología , Células Cultivadas , Células Endoteliales/citología , Células Endoteliales/metabolismo , Fluorometría , Expresión Génica/efectos de los fármacos , Histamina/farmacología , Masculino , Arterias Mesentéricas/fisiología , Microscopía Confocal , Microscopía por Video , NG-Nitroarginina Metil Éster/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Wistar , Receptor de Melatonina MT2/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Vasodilatación/efectos de los fármacosRESUMEN
Temos em nossa equipe dez personalidades diferentes, todas povoadas por fantasias, alegrias, dúvidas, amizades, medo e diversos questionamentos. Em nossas atividades diárias, somos também questionadas e, por várias vezes, temos de lidar com todos esses sentimentos, os quais såo tratados por meio de conversas informais nas consultas, em visitas domiciliares, etc. Surgiu, entåo a necessidade de tratar essas dúvidas, e daí o desafio de trabalhar em grupo e de nos aproximar mais do nosso próprio universo, o feminino. Portanto, a escolha da equipe em trabalhar com grupos de mulheres tem como objetivo aproximar as profissionais de saúde de suas 'companheiras', enquanto parte de um mesmo mundo, o feminino. Para tanto, såo realizados acolhimentos; é promovido o estímulo ao relato de experiências; luta-se para favorecer a troca entre as mulheres e a equipe; busca-se melhorar a auto-estima e discutem-se conceitos e pre-conceitos do universo feminino. Mudanças sutis já såo perceptíveis. Observamos o desenvolvimento e o fortalecimento do grupo, bem com a conscientizaçåo das mulheres em busca do seu bem-estar.
Asunto(s)
Salud de la Familia , MujeresRESUMEN
The rat pineal gland possesses P2 receptors which potentiate the effect of noradrenaline-induced N'-acetyl-5-hydroxytryptamine (N'-acetyl-5-HT) production. In the current study, this receptor was characterised according to agonist selectivity and signal transduction mechanisms. 2-MethylthioATP (2MeSATP), 2-chloroATP (2-ClATP), adenosine 5'-O-2-thiodiphosphate, (ADPbetaS), ATP and ADP, but not UTP, potentiated noradrenaline-induced N'-acetyl-5-HT production in a concentration-dependent manner. 2MeSATP neither induced the production of adenosine 3':5'-cyclic monophosphate (cyclic AMP), nor inhibited its formation when the glands were stimulated by forskolin. The phospholipase C inhibitor 1-[6-[[(17beta)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U73122), but not the inactive analogue, 1-[6-[[(17beta)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5-pyrrolidinedione (U73343), blocked the 2MeSATP effect. The P2 receptor antagonist pyridoxalphosphate-6-azophenyl-2',4'-dissulphonic acid (PPADS), which inhibits phospholipase C-coupled P2Y(1) receptors, blocked the 2MeSATP effect. In conclusion, our data strongly suggest that the P2-like receptor that is present in rat pinealocytes and which is responsible for the potentiation of noradrenaline-induced N'-acetyl-5-HT production is a P2Y(1)-like receptor, coupled to a G protein which stimulates phospholipase C.
Asunto(s)
Adenosina Difosfato/análogos & derivados , Adenosina Difosfato/farmacología , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/farmacología , AMP Cíclico/metabolismo , Glándula Pineal/efectos de los fármacos , Receptores Purinérgicos P2/efectos de los fármacos , Serotonina/metabolismo , Agonistas alfa-Adrenérgicos/farmacología , Animales , Células Cultivadas , Femenino , Masculino , Norepinefrina/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Glándula Pineal/metabolismo , Inhibidores de Agregación Plaquetaria/farmacología , Fosfato de Piridoxal/análogos & derivados , Fosfato de Piridoxal/farmacología , Ratas , Ratas Wistar , Receptores Purinérgicos P2/metabolismo , Receptores Purinérgicos P2Y1 , Serotonina/análogos & derivados , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Tionucleótidos/farmacología , Fosfolipasas de Tipo C/antagonistas & inhibidores , Fosfolipasas de Tipo C/metabolismoRESUMEN
ATP is coreleased with noradrenaline in several noradrenergic synapses, and P2-like receptors were shown to be present in rat pineal glands. A new method of functional investigation was developed to assess the importance of both transmitters (noradrenaline and ATP) in eliciting the synthesis of melatonin and its precursor N'-acetyl-5-hydroxytryptamine (N'-acetyl-5-HT) through transmural electrical field stimulation of cultured pineal glands. Incubation with the beta-adrenoceptor antagonist propranolol (>10(-7) M) blocked almost completely the production of N'-acetyl-5-HT, whilst the P2 receptor antagonists pyridoxalphosphate-6 azophenyl-2',4'-disulfonic acid (PPADS, >3x10(-6) M) and suramin (>10(-6) M) blocked it partially. These findings indicate a physiologically relevant role for the purinergic cotransmission in this system.
Asunto(s)
Adenosina Trifosfato/metabolismo , Norepinefrina/metabolismo , Glándula Pineal/metabolismo , Fosfato de Piridoxal/análogos & derivados , Serotonina/análogos & derivados , Transmisión Sináptica/fisiología , Antagonistas Adrenérgicos beta/farmacología , Animales , Relación Dosis-Respuesta a Droga , Estimulación Eléctrica , Femenino , Técnicas In Vitro , Masculino , Melatonina/metabolismo , Glándula Pineal/efectos de los fármacos , Glándula Pineal/inervación , Propranolol/farmacología , Fosfato de Piridoxal/farmacología , Ratas , Ratas Wistar , Serotonina/metabolismo , Suramina/farmacología , Factores de TiempoAsunto(s)
Pérdida de Hueso Alveolar/cirugía , Incisivo/anomalías , Raíz del Diente/anomalías , Implantes Absorbibles , Trasplante Óseo , Colágeno , Legrado , Femenino , Estudios de Seguimiento , Liofilización , Regeneración Tisular Guiada Periodontal/métodos , Humanos , Incisivo/cirugía , Membranas Artificiales , Persona de Mediana Edad , Aplanamiento de la Raíz , Colgajos Quirúrgicos , Conservación de Tejido , Raíz del Diente/cirugía , Trasplante HomólogoRESUMEN
Bondable reinforcement ribbon can be used in dentistry to splint periodontally involved teeth, to provide postorthodontic splinting, to reinforce provisional prostheses, and to fabricate direct adhesive prostheses. Four cases illustrate esthetically and functionally successful use of reinforced ribbon.
Asunto(s)
Materiales Dentales , Dentadura Parcial Inmediata , Aparatos Ortodóncicos , Ferulas Periodontales , Polietilenos , Femenino , Humanos , Persona de Mediana EdadRESUMEN
1. The effects of noradrenaline, ATP, adenylyl-imidodiphosphate (AMP-PNP), adenosine, alpha,beta-methylene-ATP and the P2-purinoceptor antagonist, suramin on N'-acetyl-5-hydroxytryptamine production were studied in cultured denervated rat pineal glands. 2. Noradrenaline (3 nM-1 microM) increased N'-acetyl-5-hydroxytryptamine production as measured both in the gland and the culture medium. 3. In noradrenaline (10 nM)-stimulated pineal glands, ATP (0.03 nM-1 mM) or AMP-PNP (0.1 microM-1 mM) increased N'-acetyl-5-hydroxytryptamine production in a concentration-dependent manner. 4. Alpha,beta-Methylene-ATP at the concentration of 0.1 mM, but not 3 microM, attenuated the enhancement by ATP (0.1 mM) of noradrenaline (10 nM)-induced N'-acetyl-5-hydroxytryptamine production. 5. Suramin (0.1 mM) blocked the potentiating effect of ATP (0.1 mM), but not the potentiating effect of adenosine (0.1 mM) in glands incubated with noradrenaline (10 nM). 6. These findings suggest that the rat pineal gland possesses P2-purinoceptors which when stimulated potentiate the effect of noradrenaline but do not, by themselves, induce an increase in N'-acetyl-5-hydroxytryptamine production.
Asunto(s)
Glándula Pineal/metabolismo , Receptores Purinérgicos P2/metabolismo , Adenosina/farmacología , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/antagonistas & inhibidores , Adenosina Trifosfato/farmacología , Adenilil Imidodifosfato/farmacología , Animales , Cromatografía Líquida de Alta Presión , Electroquímica , Femenino , Técnicas In Vitro , Masculino , Norepinefrina/metabolismo , Norepinefrina/farmacología , Glándula Pineal/efectos de los fármacos , Ratas , Ratas Wistar , Receptores Purinérgicos P2/efectos de los fármacos , Serotonina/análogos & derivados , Serotonina/metabolismo , Suramina/farmacologíaRESUMEN
Monotherapy is the policy for management of patients with epilepsy. With increasing knowledge of the biology of epilepsy and of the modes of action of antiepileptic drugs (AEDs), this concept must be reevaluated. When monotherapy fails to control seizures, subsequent treatment should be based on "rational pharmacology," taking into consideration the mode of action of the drugs, to provide improved efficacy with maintained tolerance and ease of administration. Introduction of vigabatrin (VGB) as a new AED calls for just such a reevaluation. VGB is an enzyme-activated irreversible inhibitor of gamma-aminobutyric acid (GABA)-transaminase that increases brain and cerebrospinal (CSF) GABA concentrations in animals and humans. It has limited efficacy in the classic animal seizure screening tests, but in many clinical studies has halved the incidence of seizures in approximately 50% of patients, especially those with partial epilepsies. We evaluated the efficacy of VGB in "socially integrated and active outpatients" as a likely subset to demonstrate any advantage of rational polytherapy. The criteria for this evaluation included the effects on seizure frequency, patient tolerability, and cognitive performance in a battery of psychometric tests. Fourteen of the 19 patients (73%) completing the study had > 50% reduction in seizure frequency, and 10 of 19 (52%) had > 70% reduction in seizure frequency. Tolerability appeared good; somnolence was the most frequent adverse event. Three patients complained of a worsening of their seizures, 1 with an increase in frequency and 2 with development of myoclonic jerks not previously reported.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Aminocaproatos/uso terapéutico , Anticonvulsivantes/uso terapéutico , Epilepsia/tratamiento farmacológico , Adolescente , Adulto , Anciano , Atención Ambulatoria , Aminocaproatos/efectos adversos , Aminocaproatos/farmacología , Anticonvulsivantes/efectos adversos , Anticonvulsivantes/farmacología , Cognición/efectos de los fármacos , Quimioterapia Combinada , Epilepsia/diagnóstico , Epilepsia/psicología , Femenino , Humanos , Masculino , Recuerdo Mental/efectos de los fármacos , Persona de Mediana Edad , Placebos , Pruebas Psicológicas , Índice de Severidad de la Enfermedad , Método Simple Ciego , Sueño/efectos de los fármacos , Resultado del Tratamiento , VigabatrinRESUMEN
Cognitive function of patients on monotherapy specific for their epileptic syndrome has been studied infrequently. We evaluated 7 patients with symptomatic localised epilepsies (SEL) on phenytoin aged 30 +/- 12 (mean +/- standard deviation) years, 8 with idiopathic generalised epilepsies on sodium valproate aged 18 +/- 4 years, 16 with SEL on carbamazepine aged 28 +/- 11 years, and 35 healthy controls aged 27 +/- 11 years. All subjects were of normal intelligence, educated appropriately to age, and led productive lives in the community. Two of the patients on carbamazepine and one on valproate had less than five partial, absence or myoclonic seizures monthly, the remaining were controlled. Carbamazepine serum concentrations were 12 +/- 5 micrograms/ml, phenytoin were 23 +/- 7, and valproate were 62 +/- 23 (mean +/- sd). Tests included immediate recall and recognition for pictures, Stroop test, delayed recall and recognition of pictures. Patients on phenytoin and valproate performed significantly worse than controls on immediate recall, and patients on carbamazepine performed significantly worse than controls in Stroop test (p < 0.01). The results indicate relatively minor effects of the epileptic syndromes and of phenytoin, carbamazepine and valproate on cognition of patients with controlled epilepsy leading productive lives in the community. We conclude that the cognitive deficit found in chronic epileptic patients on poly-therapeutic drug regimen must be multifactorial, and that future studies need to control for all possible variables in order to achieve meaningful results.
Asunto(s)
Cognición , Epilepsia/psicología , Adolescente , Adulto , Carbamazepina/sangre , Carbamazepina/uso terapéutico , Niño , Cognición/efectos de los fármacos , Epilepsia/sangre , Epilepsia/tratamiento farmacológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fenitoína/sangre , Fenitoína/uso terapéutico , Estudios Prospectivos , Ácido Valproico/sangre , Ácido Valproico/uso terapéuticoRESUMEN
The work aims to investigate the influence of positive pressure to initial and final setting time, as well as the volume variation in course of the pressure carried out gypsum-bonded investment found at Dental Commerce. Seventy-six test samples were obtained, being five of them through conventional investing technique and seventy-one through technique by pressure. Gillmore needles were employed for determining the setting time, meanwhile for volumetric variation a mathematic formula had been applied. According to results, it was concluded that the use of positive pressure affected the initial and the final setting time and the volume after set.